Literature DB >> 16029426

Reconstitution of a human immune system in immunodeficient mice: models of human alloreaction in vivo.

M Thomsen1, H Yacoub-Youssef, B Marcheix.   

Abstract

Rodents have been widely used for studies in transplantation immunology because of their short reproduction period and the relative ease of generating inbred mutant or transgenic strains. However, although many biological mechanisms are similar between rodents and humans, several features clearly distinguish the immune system in these species. Consequently, it is rarely possible to extrapolate observations from rodent models directly into clinical practice. In vitro studies with human cells are useful for elucidation of basic mechanisms, but in order to study complex biological phenomena, in vivo studies are indispensable. In later years, a number of interesting models have been described where immunodeficient mice have been reconstituted with human cells, so-called humanized mice, in order to study human immune responses in vivo. This has opened a new field of experimental immunology that has been applied to areas such as cancer, autoimmunity, allergy, infections, and transplantation biology. In this review, we shall concentrate on the use of severe combined immunodeficient mice reconstituted with human immune or stem cells for studies of human alloreaction in vivo.

Entities:  

Mesh:

Year:  2005        PMID: 16029426     DOI: 10.1111/j.1399-0039.2005.00409.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  9 in total

Review 1.  Murine models to evaluate novel and conventional therapeutic strategies for cancer.

Authors:  James E Talmadge; Rakesh K Singh; Isaiah J Fidler; Avraham Raz
Journal:  Am J Pathol       Date:  2007-03       Impact factor: 4.307

2.  Generation of knockout rats with X-linked severe combined immunodeficiency (X-SCID) using zinc-finger nucleases.

Authors:  Tomoji Mashimo; Akiko Takizawa; Birger Voigt; Kazuto Yoshimi; Hiroshi Hiai; Takashi Kuramoto; Tadao Serikawa
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

3.  Derivation of lung epithelium from human cord blood-derived mesenchymal stem cells.

Authors:  Viranuj Sueblinvong; Roberto Loi; Philip L Eisenhauer; Ira M Bernstein; Benjamin T Suratt; Jeffrey L Spees; Daniel J Weiss
Journal:  Am J Respir Crit Care Med       Date:  2007-12-06       Impact factor: 21.405

4.  Humanized mouse model of glucose 6-phosphate dehydrogenase deficiency for in vivo assessment of hemolytic toxicity.

Authors:  Rosemary Rochford; Colin Ohrt; Paul C Baresel; Brice Campo; Aruna Sampath; Alan J Magill; Babu L Tekwani; Larry A Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-07       Impact factor: 11.205

Review 5.  Nanoparticle characterization: state of the art, challenges, and emerging technologies.

Authors:  Eun Jung Cho; Hillary Holback; Karen C Liu; Sara A Abouelmagd; Joonyoung Park; Yoon Yeo
Journal:  Mol Pharm       Date:  2013-03-21       Impact factor: 4.939

Review 6.  Humanized Mouse Models for Transplant Immunology.

Authors:  L L Kenney; L D Shultz; D L Greiner; M A Brehm
Journal:  Am J Transplant       Date:  2015-11-20       Impact factor: 8.086

7.  Safety concerns on the development of novel therapeutic drugs.

Authors:  Caroline Ospelt; Steffen Gay
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

8.  Evaluating Human Immune Responses for Vaccine Development in a Novel Human Spleen Cell-Engrafted NOD-SCID-IL2rγNull Mouse Model.

Authors:  Stéphanie Ghosn; Soulaima Chamat; Eric Prieur; Antoine Stephan; Pierre Druilhe; Hasnaa Bouharoun-Tayoun
Journal:  Front Immunol       Date:  2018-03-23       Impact factor: 7.561

9.  Immunoglobulin-like transcript 3-Fc suppresses T-cell responses to allogeneic human islet transplants in hu-NOD/SCID mice.

Authors:  George Vlad; Vivette D D'Agati; Qing-Yin Zhang; Zhuoru Liu; Eric K Ho; Thalachallour Mohanakumar; Mark A Hardy; Raffaello Cortesini; Nicole Suciu-Foca
Journal:  Diabetes       Date:  2008-04-16       Impact factor: 9.461

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.